home.aspx
 
EVENTS

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...

Symposium on Advanced Wound Care Fall
SYMPOSIUM ON ADVANCED WOUND CARE FALL
October 30-01, 2020
The Symposium on Advanced Wound Care Fall meeting (SAWC Fall) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes thro...

Acro Pharmaceutical Services

SHARESHARESHARE
Acro Pharmaceutical Services (Acro) dispenses specialty medications directly to physician offices and to patients’ homes throughout the United States. The prescription drugs that Acro dispenses typically require special handling, clinical and financial support services. The cost of these specialty medications is much higher than those dispensed through retail pharmacies. Acro Pharmaceutical Services offers online pharmacy services such as prescription refills, prior authorization forms, and other services to assist the patient and provider. There are a growing number of specialty drugs available to patients. These specialty medications often focus on, but are not limited to, specific disease states such as Multiple Sclerosis, Psoriasis, Rheumatoid Arthritis, growth hormone deficiency, blood clotting disorders, types of cancer, pulmonary diseases, addiction treatment, mental health disorders, gastrointestinal diseases, rare orphan diseases and many others.
SHARESHARESHARE

RELATED NEWS


Acceleron has announced the discontinuation of the development of its drug intended for facioscapulohumeral muscular dystrophy (FSHD), ACE-083. The drug did not achieve statistically significant improvements in functional endpoints relative to placebo in a Phase II trial, which means that Acceleron will not conduct further clinical trials. Although the drug demonstrated a robust, statistically significant increase in mean total muscle volume, the primary endpoint of the trial, the increase faile...

READ MORE

Some migraine sufferers in the UK hoping to get access to Novartis’ new migraine prevention drug Aimovig are facing disappointment after NICE rejected it in the draft guidance. The cost-effectiveness watchdog says that it can’t recommend routine NHS use of Aimovig (erenumab) for people suffering at least four migraine episodes each month, even though it is only intended for use after three earlier oral treatments have failed. Aimovig became the first drug in a new class of antib...

READ MORE

In a recent preliminary study, scientists used stem cells to ease osteoarthritis. Although the trial was small-scale, the results are promising and will pave the way for larger studies. Osteoarthritis of the knee (KOA) occurs when the cartilage — the joint's natural cushioning system — breaks down in the knee. Without this buffer, bones can come into contact with each other, causing pain, stiffness, and a loss of flexibility. According to the Centers for Disease Control and Preve...

READ MORE

Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO, Stephen J. Ubl, issued the following statement: “PhRMA congratulates Chairman Tom Price, M.D. on his nomination as Secretary of Health and Human Services. His vast health care experience and knowledge will be a great asset to the Agency. PhRMA also congratulates Seema Verma on her nomination to lead the Center for Medicare and Medicaid Services. We look forward to working with Dr. Price and Ms. Verma in their new rol...
PHRMA.ORG
READ MORE

The first trial to test the safety and efficacy of a reversible male contraceptive gel is underway. If approved, this could be the first male hormonal birth control on the market. “This gel reduces sperm count to a contraceptive level,” Clint Dart, the Vice President, Biostatistics and Programming at Health Decisions (the CRO running the study), exclusively told BioSpace. “Once a man’s sperm concentration is low enough (less than 1 million/mL), there is a 97 percent chanc...

READ MORE

A trial of Roche’s successor to flu medicine Tamiflu has met its goal in a phase 3 trial, with results showing that the new drug Xofluza is well tolerated in children with the flu. Roche’s Genentech unit said the MINISTONE-2 study also showed Xofluza is comparable with Tamiflu (oseltamivir) in terms of efficacy, the drug that Xofluza is designed to replace. The idea behind Xofluza (baloxavir marboxil) is to replace Tamiflu’s once-daily dosing regimen with a single dose that hel...

READ MORE

EVENTS

Symposium on Advanced Wound Care Fall
SYMPOSIUM ON ADVANCED WOUND CARE FALL
October 30-01, 2020
The Symposium on Advanced Wound Care Fall meeting (SAWC Fall) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes thro...

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.